Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Neratinib in Treating Older Patients With Stage IV HER2-Positive Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02673398
Recruitment Status : Active, not recruiting
First Posted : February 3, 2016
Last Update Posted : December 17, 2020
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
City of Hope Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : October 22, 2021
Estimated Study Completion Date : October 22, 2021